Royalty Pharma PLC (RPRX)
26.43
+0.03
(+0.11%)
USD |
NASDAQ |
Nov 22, 16:00
26.41
-0.02
(-0.08%)
After-Hours: 20:00
Royalty Pharma Price: 26.43 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 26.38 | 26.63 | 26.33 | 26.43 | 2.461M |
| Nov 21, 2024 | 26.26 | 26.66 | 26.23 | 26.40 | 4.330M |
| Nov 20, 2024 | 26.09 | 26.29 | 25.80 | 26.22 | 2.007M |
| Nov 19, 2024 | 25.63 | 26.03 | 25.47 | 26.01 | 7.299M |
| Nov 18, 2024 | 25.76 | 25.94 | 25.51 | 25.80 | 4.725M |
| Nov 15, 2024 | 25.23 | 25.88 | 25.10 | 25.70 | 3.846M |
| Nov 14, 2024 | 25.90 | 25.96 | 25.36 | 25.58 | 3.031M |
| Nov 13, 2024 | 26.00 | 26.20 | 25.80 | 25.85 | 2.529M |
| Nov 12, 2024 | 26.25 | 26.41 | 25.82 | 26.00 | 3.148M |
| Nov 11, 2024 | 26.30 | 26.60 | 26.12 | 26.36 | 2.785M |
| Nov 08, 2024 | 26.61 | 26.80 | 26.08 | 26.21 | 5.979M |
| Nov 07, 2024 | 27.01 | 27.03 | 26.30 | 26.52 | 2.583M |
| Nov 06, 2024 | 28.13 | 28.36 | 26.56 | 26.64 | 4.599M |
| Nov 05, 2024 | 27.12 | 27.56 | 26.95 | 27.54 | 1.820M |
| Nov 04, 2024 | 27.52 | 27.59 | 27.16 | 27.20 | 1.603M |
| Nov 01, 2024 | 27.00 | 27.27 | 26.99 | 27.10 | 1.810M |
| Oct 31, 2024 | 27.08 | 27.26 | 26.96 | 27.00 | 1.900M |
| Oct 30, 2024 | 27.07 | 27.37 | 26.94 | 27.19 | 2.518M |
| Oct 29, 2024 | 27.13 | 27.33 | 27.08 | 27.15 | 1.832M |
| Oct 28, 2024 | 27.10 | 27.28 | 27.02 | 27.26 | 1.985M |
| Oct 25, 2024 | 27.35 | 27.38 | 26.94 | 26.95 | 1.629M |
| Oct 24, 2024 | 27.24 | 27.45 | 27.18 | 27.28 | 1.591M |
| Oct 23, 2024 | 27.27 | 27.49 | 27.19 | 27.36 | 1.449M |
| Oct 22, 2024 | 27.60 | 27.70 | 27.32 | 27.37 | 2.383M |
| Oct 21, 2024 | 27.95 | 28.00 | 27.64 | 27.75 | 1.693M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.58
Minimum
Nov 14 2024
52.82
Maximum
Jan 26 2021
36.88
Average
38.72
Median
Aug 18 2021
Price Benchmarks
| Geron Corp | 4.07 |
| Amicus Therapeutics Inc | 9.66 |
| Ionis Pharmaceuticals Inc | 34.01 |
| Arbutus Biopharma Corp | 3.51 |
| Syndax Pharmaceuticals Inc | 16.09 |
Price Related Metrics
| PE Ratio | 10.36 |
| PS Ratio | 6.953 |
| Price to Book Value | 1.709 |
| Price to Free Cash Flow | 5.629 |
| Earnings Yield | 9.65% |
| Market Cap | 11.74B |
| Operating PE Ratio | 10.21 |
| Normalized PE Ratio | 13.49 |